Thierry O Philip


Ontology type: schema:Person     


Person Info

NAME

Thierry O

SURNAME

Philip

Publications in SciGraph latest 50 shown

  • 2019-11-15 Cost-effectiveness of an exercise and nutritional intervention versus usual nutritional care during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial in SUPPORTIVE CARE IN CANCER
  • 2019-05-11 Agricultural and domestic pesticides in house dust from different agricultural areas in France in ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
  • 2015-03-17 Estimated dietary dioxin exposure and breast cancer risk among women from the French E3N prospective cohort in BREAST CANCER RESEARCH
  • 2014-08-04 Studying the impact of early life exposures to pesticides on the risk of testicular germ cell tumors during adulthood (TESTIS project): study protocol in BMC CANCER
  • 2007-12 Douleur et cancer: informations à l’usage des personnes malades et de leurs proches in DOULEUR ET ANALGÉSIE
  • 2006-07 Éditorial in ONCOLOGIE
  • 2006-06 Soins spécifiques et soins de support en cancérologie à domicile: expérience du centre Léon-Bérard sur 751 patients en 2003 in ONCOLOGIE
  • 2005-05 Soins de support: état des réflexions en Europe in ONCOLOGIE
  • 2003-08-15 European cooperation for clinical practice guidelines in cancer in BRITISH JOURNAL OF CANCER
  • 2003-08-15 The SOR SAVOIR PATIENT project–an evidence-based patient information and education project in BRITISH JOURNAL OF CANCER
  • 2002-11-12 The LMCE5 unselected cohort of 25 children consecutively diagnosed with untreated stage 4 neuroblastoma over 1 year at diagnosis in BRITISH JOURNAL OF CANCER
  • 2002-02-11 A controlled ‘before-after’ study: impact of a clinical guidelines programme and regional cancer network organization on medical practice in BRITISH JOURNAL OF CANCER
  • 2001-11-27 Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study) in BRITISH JOURNAL OF CANCER
  • 2001-08-26 Legal effects of the Standards, Options and Recommandations (SOR) project on French Cancer Centers in BMC NEWS AND VIEWS
  • 2001-05 SOR Project: the French context in BRITISH JOURNAL OF CANCER
  • 2001-05 SOR: project methodology in BRITISH JOURNAL OF CANCER
  • 2001-05-01 Osteosarcoma in BRITISH JOURNAL OF CANCER
  • 2001-05-01 SOR: project methodology in BRITISH JOURNAL OF CANCER
  • 2001-05-01 Hodgkins disease in BRITISH JOURNAL OF CANCER
  • 2001-05-01 SOR Project: the French context in BRITISH JOURNAL OF CANCER
  • 1999-09 High-dose methotrexate and HELP [Holoxan (ifosfamide), Eldesine (vindesine), platinum] - doxorubicin in non-metastatic osteosarcoma of the extremity: A French multicentre pilot study in ANNALS OF ONCOLOGY
  • 1999-05 Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99 m skeletal angioscintigraphy in EUROPEAN RADIOLOGY
  • 1998-01-01 High-dose chemotherapy with hematopoietic stem cell transplantation in patients with mantle cell or diffuse centrocytic non-Hodgkin’s lymphomas: a single center experience on 18 patients in BONE MARROW TRANSPLANTATION
  • 1997-04 Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression in BRITISH JOURNAL OF CANCER
  • 1997-01 Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma in BRITISH JOURNAL OF CANCER
  • 1997-01 High-dose carmustine for high-grade gliomas in childhood in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1997 High-dose chemotherapy in non-Hodgkin’s lymphoma in ADVANCES IN LYMPHOMA RESEARCH
  • 1996-12 Tolerance Evaluation of L-asparaginase loaded in red blood cells in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 1995-06 Is neuroblastoma screening evaluation needed and feasible? in BRITISH JOURNAL OF CANCER
  • 1995 Adoptive Immunotherapy with Interleukin-2 and LAK Cells or Gene Modified TIL in Patients with Renal Cell Carcinoma: Clinical and Laboratory Data in BIOLOGY OF RENAL CELL CARCINOMA
  • 1994-07 High-dose VP 16 cisplatinum in soft tissue sarcoma of children in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1994-06 Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma in BRITISH JOURNAL OF CANCER
  • 1994-01 Pretreatment serum CRP and response to interleukin 2 in BRITISH JOURNAL OF CANCER
  • 1994 Interleukin-2 Therapy: Report on 129 Patients and Three Different Schedules in CONTEMPORARY RESEARCH ON RENAL CELL CARCINOMA
  • 1994 Clinical application of gene transfer in oncology: preliminary results of a French study in CANCER TREATMENT AN UPDATE
  • 1993-11 Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients in BRITISH JOURNAL OF CANCER
  • 1993-07 Phase II study of fotemustine as second-line treatment after failure of immunotherapy in metastatic renal cell carcinoma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1993-05 Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring in BRITISH JOURNAL OF CANCER
  • 1993-02 Successfull treatment for a metastatic supratentorial malignant rhabdoid tumor in JOURNAL OF NEURO-ONCOLOGY
  • 1993 Interleukin-2 and lymphokine activated killer (LAK) cells in THE ROLE OF INTERLEUKIN-2 IN THE TREATMENT OF CANCER PATIENTS
  • 1993-01 Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study in BRITISH JOURNAL OF CANCER
  • 1992-10 Kidney in INTENSIVE CARE MEDICINE
  • 1992-05 Intravenous interleukin-2 in patients over 65 with metastatic renal carcinoma in BRITISH JOURNAL OF CANCER
  • 1991-01 Renal effects of continuous infusion of recombinant interleukin-2 in children in PEDIATRIC NEPHROLOGY
  • 1991 Immunotherapy in metastatic renal cell cancer. The Lyon’s experience on 100 patients in PROCEEDINGS OF THE 3RD INTERNATIONAL CONGRESS ON NEO-ADJUVANT CHEMOTHERAPY
  • 1990 Adoptive Immunotherapy with IL-2 in 27 Patients with Metastatic Renal Cell Carcinoma in CYTOKINES IN HEMOPOIESIS, ONCOLOGY, AND AIDS
  • 1990 Stimulation of the Immune System for the Therapy of Advanced Stage Neuroblastoma in EXPERIMENTAL HEMATOLOGY TODAY—1989
  • 1990 rIL-2 Immunotherapy for 19 Children with Advanced Metastatic Neuroblastoma in CYTOKINES IN HEMOPOIESIS, ONCOLOGY, AND AIDS
  • 1989-06 Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation in BRITISH JOURNAL OF CANCER
  • 1989-02 High-dose melphalan dosage adjustment: possibility of using a test-dose in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.418596.7", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.420146.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414282.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411167.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418116.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.264200.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414362.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.459687.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418189.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.493186.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411158.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7429.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.508487.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412370.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412180.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.14925.3b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418064.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10417.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.17703.32", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.439749.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.25073.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7849.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418451.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416346.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417616.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414427.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.452351.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.477174.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412954.f", 
            "type": "Organization"
          }
        ], 
        "familyName": "Philip", 
        "givenName": "Thierry O", 
        "id": "sg:person.01206344634.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206344634.91"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-11-24T21:36", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/person/person_680.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01206344634.91'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01206344634.91'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01206344634.91'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01206344634.91'


     

    This table displays all metadata directly associated to this object as RDF triples.

    72 TRIPLES      10 PREDICATES      39 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01206344634.91 schema:affiliation N969f20279da747d3882c0b0ef696323b
    2 grid-institutes:grid.10417.33
    3 grid-institutes:grid.14925.3b
    4 grid-institutes:grid.17703.32
    5 grid-institutes:grid.25073.33
    6 grid-institutes:grid.264200.2
    7 grid-institutes:grid.411158.8
    8 grid-institutes:grid.411167.4
    9 grid-institutes:grid.412180.e
    10 grid-institutes:grid.412370.3
    11 grid-institutes:grid.412954.f
    12 grid-institutes:grid.414282.9
    13 grid-institutes:grid.414362.6
    14 grid-institutes:grid.414427.0
    15 grid-institutes:grid.416346.2
    16 grid-institutes:grid.417616.3
    17 grid-institutes:grid.418064.f
    18 grid-institutes:grid.418116.b
    19 grid-institutes:grid.418189.d
    20 grid-institutes:grid.418451.d
    21 grid-institutes:grid.420146.5
    22 grid-institutes:grid.439749.4
    23 grid-institutes:grid.452351.4
    24 grid-institutes:grid.459687.1
    25 grid-institutes:grid.477174.6
    26 grid-institutes:grid.493186.1
    27 grid-institutes:grid.508487.6
    28 grid-institutes:grid.7429.8
    29 grid-institutes:grid.7849.2
    30 schema:familyName Philip
    31 schema:givenName Thierry O
    32 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206344634.91
    33 schema:sdDatePublished 2022-11-24T21:36
    34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    35 schema:sdPublisher Nb9e5bb4992984cbc8fa778cecfe271f0
    36 sgo:license sg:explorer/license/
    37 sgo:sdDataset persons
    38 rdf:type schema:Person
    39 N969f20279da747d3882c0b0ef696323b schema:affiliation grid-institutes:grid.418596.7
    40 sgo:isCurrent true
    41 rdf:type schema:OrganizationRole
    42 Nb9e5bb4992984cbc8fa778cecfe271f0 schema:name Springer Nature - SN SciGraph project
    43 rdf:type schema:Organization
    44 grid-institutes:grid.10417.33 schema:Organization
    45 grid-institutes:grid.14925.3b schema:Organization
    46 grid-institutes:grid.17703.32 schema:Organization
    47 grid-institutes:grid.25073.33 schema:Organization
    48 grid-institutes:grid.264200.2 schema:Organization
    49 grid-institutes:grid.411158.8 schema:Organization
    50 grid-institutes:grid.411167.4 schema:Organization
    51 grid-institutes:grid.412180.e schema:Organization
    52 grid-institutes:grid.412370.3 schema:Organization
    53 grid-institutes:grid.412954.f schema:Organization
    54 grid-institutes:grid.414282.9 schema:Organization
    55 grid-institutes:grid.414362.6 schema:Organization
    56 grid-institutes:grid.414427.0 schema:Organization
    57 grid-institutes:grid.416346.2 schema:Organization
    58 grid-institutes:grid.417616.3 schema:Organization
    59 grid-institutes:grid.418064.f schema:Organization
    60 grid-institutes:grid.418116.b schema:Organization
    61 grid-institutes:grid.418189.d schema:Organization
    62 grid-institutes:grid.418451.d schema:Organization
    63 grid-institutes:grid.418596.7 schema:Organization
    64 grid-institutes:grid.420146.5 schema:Organization
    65 grid-institutes:grid.439749.4 schema:Organization
    66 grid-institutes:grid.452351.4 schema:Organization
    67 grid-institutes:grid.459687.1 schema:Organization
    68 grid-institutes:grid.477174.6 schema:Organization
    69 grid-institutes:grid.493186.1 schema:Organization
    70 grid-institutes:grid.508487.6 schema:Organization
    71 grid-institutes:grid.7429.8 schema:Organization
    72 grid-institutes:grid.7849.2 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...